new glp 1 drug retatrutide Promises Big Weight Loss, but Safety Remains a Question Lilly orforglipron oral GLP-1 phase

Research-only supply (21+) Products are supplied strictly for laboratory research use

Any retatrutide obtained outside of a formal, ethics-approved clinical trial is classified as a research chemical and is not intended for human use under current UK regulations

Discuss how the impairment impacts social or occupational functioning, such as absences from work or inability to care for children

The weight loss you achieve at 4mg while waiting is still meaningful

About one in seven adults who have ever used GLP-1 medications say they are no longer using these drugs because of the cost (14%), similar to the share who report no longer taking the medications because of side effects (13%)